04-May-2010 - Cardiac monitoring and ePRO specialist ERT has added respiratory diagnostics and device manufacturing services to its offering with the acquisition of CareFusion Research Services (CRS) for $81m (€61m).
26-Apr-2010 - Charles River Laboratories (CRL) is to acquire WuXi PharmaTech for $1.6bn (€1.2bn), creating a global CRO capable of offering fully integrated services from molecule creation to first-in-human testing.
26-Apr-2010 - US CRO Medpace has move into medical device trials with acquisition of Symbios Clinical in a bid to tap into what CEO August Troendle said was a growth area for...
19-Apr-2010 - IT giant Oracle will pay $685m (€507m) for eClinical solutions firm Phase Forward, significantly expanding its presence in the billion dollar contract clinical research sector.
06-Apr-2010 - Clearstone is expanding safety and esoteric capacity at its laboratory in Toronto, Canada, allowing it to close its facility in New Jersey, US and consolidate North American operations.
23-Mar-2010 - IRL and Epichem have entered into a strategic alliance to provide the Australasian pharma market with services from drug discovery through to cGMP production.
17-Feb-2010 - The capabilities of the MDS Pharma Services' sites Ricerca is set to acquire "perfectly dovetail" with its existing capacity, according to a company vice president.
11-Feb-2010 - Consolidation in pharma, coupled to the trend for strategic partnerships, will lead to CRO mergers, with large companies getting bigger and small firms focusing on niche opportunities, according to a...
03-Feb-2010 - Belgium-based Galapagos NV has acquired Argenta Discovery for €16.5m ($23.1m), creating a drug discovery service company with 390 employees and estimated revenues of €70m.
28-Jan-2010 - Biotechnology firm Biocon is in talks with CRO Siro Clinpharm about a potential partnership, according to reports in the Indian media.
27-Jan-2010 - Recipharm says acquisition of German CMO Wasserburger Arzneimittelwerk from Hospira adds large-scale lyophilisation services to its offering.
27-Jan-2010 - MDS believes its early stage business is likely to sell for less than previously expected because of the continued deterioration of market conditions and its declining customer base.
25-Jan-2010 - US CRO PPD has sold its biomarker discovery sciences unit to Caprion Proteomics, bucking the trend that has seen many of its sector rivals invest in this part of the...
20-Jan-2010 - Quotient Bioresearch has secured the supply of 14C labelled compounds for its customers ahead of its move to a new purpose built facility in Cardiff through an extension of its...
13-Jan-2010 - Indian CRO Siro Clinpharm has renamed its European units and plans to open offices in two more countries in the region in the next few months.
11-Jan-2010 - US clinical trial review groups Independent Review Consulting (IRC) and Ethical Review Committee (ERC) are to merge and operate under the name Ethical and Independent Review Services (E&I).
05-Jan-2010 - US CRO Commonwealth Biotechnologies (CBI) is moving forward with plans to buy Chinese peptide supplier GL Biochem.
04-Jan-2010 - Rexam will close its pill and tablet bottle making facility in New Hampshire, US by the end of the year to further align global plastics operations according to new CEO...
22-Dec-2009 - Patheon says a slowdown in “outsourcing decision making,” manufacturing problems in Puerto Rico and cost related to JLL’s takeover bid hurt it in fiscal 09.
21-Dec-2009 - US drugmaker NexMed has maintained its place on the Nasdaq Stock Exchange, partly as a result of its acquisition of US preclinical CRO Bio-Quant.
17-Dec-2009 - Swedish CDMO Recipharm will buy privately-owned group Cobra Biomanufacturing to build its presence in the expanding biologics sector.
09-Dec-2009 - German drug distribution and pharmacy firm Celesio has bought Ireland’s Alchemy Healthcare to drive its growth in the country’s contract sales sector.
01-Dec-2009 - Patheon and JLL are to end the legal actions between them by entering into a litigation settlement which establishes a board of directors and limits JLL acquiring additional restricted voting...
26-Nov-2009 - The recent wave of M&A will lead to manufacturing over-capacity at pharma companies but only a small number of these sites will be sold to CMOs, in part because of...
25-Nov-2009 - US pharmaceutical firm NexMed hopes the planned acquisition of preclinical CRO Bio-Quant will help maintain its Nasdaq listing.